Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:16:50 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



C:PHRM - PharmaTher Holdings Ltd. - http://www.pharmather.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PHRM - C  6.00.25·0.298.00.27+0.02510.2121.230500.26  0.285  0.2550.43  0.08May 06May 0115 min RT 2¢
CSE - C6.00.25·0.298.00.27+0.02510.290.223290.255  0.28  0.2550.43  0.08May 0615 min
NEO ATS - U 0.28+0.03514.30.5010.28  0.28  0.28May 0615 min
Omega - O 0.27+0.02510.26.5240.265  0.27  0.265May 0615 min
Chi-X - X 0.27+0.02510.24.5130.265  0.27  0.265May 0615 min
CX2 - H 0.285+0.0416.319.05100.26  0.285  0.26May 0615 min
CXD - D 0.2450.502    Apr 1015 min
TriAct - M 0.2450.031    15 min

Recent Trades - Last 10 of 50
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:58:36C0.270.02550039 Merrill Lynch1 AnonymousK
15:58:36C0.270.02536,00079 CIBC1 AnonymousK
15:53:06C0.2750.031,0001 Anonymous79 CIBCK
15:53:06C0.2750.033,00014 Virtu ITG79 CIBCK
15:44:42C0.280.0355001 Anonymous7 TD SecK
15:44:26C0.280.0351,0001 Anonymous7 TD SecK
15:44:26C0.280.0351,0001 Anonymous7 TD SecK
14:26:35C0.2750.031,0001 Anonymous80 National BankK
14:26:35C0.2750.035001 Anonymous80 National BankK
14:26:35C0.2750.035001 Anonymous80 National BankK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-01 13:37C:PHRM0.275News ReleasePharmather, Pharmadrug complete PD-001 clinical package
2024-04-23 02:12C:PHRM0.215SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-23 02:11C:PHRM0.215SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-04-18 16:10C:PHRM0.23News ReleasePharmather receives complete response for ketamine ANDA
2024-04-16 14:03C:PHRM0.21News ReleasePharmather hopes to submit ketamine responses this week
2024-04-02 11:21C:PHRM0.385News ReleaseRevive clinical study enrolls nearly 50% of sample
2024-02-21 13:19C:PHRM0.21News ReleasePharmather, Pharmadrug begin Sairiyo plan for PD-001
2024-02-14 13:15C:PHRM0.225News ReleasePharmadrug unit to manufacture PD-001 for human studies
2024-02-12 11:12C:PHRM0.19News ReleasePharmather talks ketamine ANDA, possible deficiencies
2024-01-10 11:21C:PHRM0.225News ReleasePharmather expects FDA ketamine approval April 29, 2024
2023-10-30 19:15C:PHRM0.135SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-10-30 19:15C:PHRM0.135SEDAR Interim MD & ASEDAR Interim MD & A
2023-09-28 18:20C:PHRM0.14SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-09-27 10:36C:PHRM0.15News ReleasePharmather's Ketarx drug application accepted by FDA
2023-09-06 10:38C:PHRM0.14News ReleasePharmather submits new drug application for Ketarx
2023-07-18 10:06C:PHRMNews ReleasePharmather completes PharmaPatch research study
2023-06-27 12:05C:PHRM0.15News ReleasePharmather files presubmission facility correspondence
2023-06-20 07:51C:PHRM0.105News ReleasePharmather, Vitruvias to collaborate for Ketarx
2023-06-12 09:36C:PHRM0.095News ReleasePharmather hopes to receive Ketarx FDA OK in Q1 2024